Loading clinical trials...
Showing 1-1 of 1 trials
NCT05747456
The primary objective of the study is to demonstrate the superiority of IPN-21-SENSE versus no treatment at 24 weeks after baseline for the creation or restoration of volume deficit in the mid-face.